The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- CA
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- RFA-DK-28-213
- Posted
- Nov 3, 2026
- Response due
- Mar 5, 2027
- Archive date
- May 5, 2027
- CFDA / Assistance listing
- 93.KRC
- Award ceiling
- $500,000
- Total program funding
- $4,500,000
- Contact
- terez.shea-donohue@nih.gov
- Source
- Grants.gov
Description
This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials. This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (RFA-DK-28-214).